Differential expression of anterior gradient gene AGR2 in prostate cancer

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Maresh, Erin L ^a   Mah, Vei ^a   Alavi, Mohammad ^a   Horvath, Steve ^a   Bagryanova, Lora ^b,c   Liebeskind, Emily S ^b,c   Knutzen, Laura A ^c   Zhou, Yong ^c   Chia, David ^a   Liu, Alvin Y ^b,c   Goodglick, Lee ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN AGR2; PROTEIN DISULFIDE ISOMERASE; RNA; UNCLASSIFIED DRUG; AGR2 PROTEIN, HUMAN; MESSENGER RNA; PROTEIN;

ADULT; AGED; AGR2 GENE; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; GENE; GENE EXPRESSION; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; ADENOCARCINOMA; DNA MICROARRAY; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PRECANCER; PROPORTIONAL HAZARDS MODEL; PROSTATE TUMOR; PROSTATECTOMY; RISK ASSESSMENT; RISK FACTOR; TISSUE MICROARRAY; TREATMENT OUTCOME; TUMOR RECURRENCE; UNITED STATES;

ADENOCARCINOMA; AGED; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LOS ANGELES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRECANCEROUS CONDITIONS; PROPORTIONAL HAZARDS MODELS; PROSTATECTOMY; PROSTATIC NEOPLASMS; PROTEINS; RISK ASSESSMENT; RISK FACTORS; RNA, MESSENGER; TISSUE ARRAY ANALYSIS; TREATMENT OUTCOME;

EID: 78649916134     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-680     Document Type: Article

References (48)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA: a cancer journal for clinicians 2010, 60(5):277-300. 10.3322/caac.20073, 20610543.
2. Pascal LE, Deutsch EW, Campbell DS, Korb M, True LD, Liu AY. The urologic epithelial stem cell database (UESC) - a web tool for cell type-specific gene expression and immunohistochemistry images of the prostate and bladder. BMC urology 2007, 7:19. 10.1186/1471-2490-7-19, 2231381, 18072977.
3. Nielsen H, Engelbrecht J, Brunak S, von Heijne G. A neural network method for identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Int J Neural Syst 1997, 8(5-6):581-599. 10.1142/S0129065797000537, 10065837.
4. Krogh A, Larsson B, von Heijne G, Sonnhammer EL. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 2001, 305(3):567-580. 10.1006/jmbi.2000.4315, 11152613.
5. Pascal LE, Vencio RZ, Page LS, Liebeskind ES, Shadle CP, Troisch P, Marzolf B, True LD, Hood LE, Liu AY. Gene expression relationship between prostate cancer cells of Gleason 3, 4 and normal epithelial cells as revealed by cell type-specific transcriptomes. BMC Cancer 2009, 9:452. 10.1186/1471-2407-9-452, 2809079, 20021671.
6. Thompson DA, Weigel RJ. hAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines. Biochemical and biophysical research communications 1998, 251(1):111-116. 10.1006/bbrc.1998.9440, 9790916.
7. Persson S, Rosenquist M, Knoblach B, Khosravi-Far R, Sommarin M, Michalak M. Diversity of the protein disulfide isomerase family: identification of breast tumor induced Hag2 and Hag3 as novel members of the protein family. Molecular phylogenetics and evolution 2005, 36(3):734-740. 10.1016/j.ympev.2005.04.002, 15935701.
8. Zweitzig DR, Smirnov DA, Connelly MC, Terstappen LW, O'Hara SM, Moran E. Physiological stress induces the metastasis marker AGR2 in breast cancer cells. Molecular and cellular biochemistry 2007, 306(1-2):255-260. 10.1007/s11010-007-9562-y, 17694278.
9. Pohler E, Craig AL, Cotton J, Lawrie L, Dillon JF, Ross P, Kernohan N, Hupp TR. The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage. Mol Cell Proteomics 2004, 3(6):534-547. 10.1074/mcp.M300089-MCP200, 14967811.
10. Ferraro A, Altieri F, Coppari S, Eufemi M, Chichiarelli S, Turano C. Binding of the protein disulfide isomerase isoform ERp60 to the nuclear matrix-associated regions of DNA. Journal of cellular biochemistry 1999, 72(4):528-539. 10.1002/(SICI)1097-4644(19990315)72:4<528::AID-JCB8>3.0.CO;2-V, 10022612.
11. Turano C, Coppari S, Altieri F, Ferraro A. Proteins of the PDI family: unpredicted non-ER locations and functions. Journal of cellular physiology 2002, 193(2):154-163. 10.1002/jcp.10172, 12384992.
12. Mandel R, Ryser HJ, Ghani F, Wu M, Peak D. Inhibition of a reductive function of the plasma membrane by bacitracin and antibodies against protein disulfide-isomerase. Proceedings of the National Academy of Sciences of the United States of America 1993, 90(9):4112-4116. 10.1073/pnas.90.9.4112, 46456, 8387210.
13. Fritzsche FR, Dahl E, Pahl S, Burkhardt M, Luo J, Mayordomo E, Gansukh T, Dankof A, Knuechel R, Denkert C, et al. Prognostic relevance of AGR2 expression in breast cancer. Clin Cancer Res 2006, 12(6):1728-1734. 10.1158/1078-0432.CCR-05-2057, 16551856.
14. Innes HE, Liu D, Barraclough R, Davies MP, O'Neill PA, Platt-Higgins A, de Silva Rudland S, Sibson DR, Rudland PS. Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients. British journal of cancer 2006, 94(7):1057-1065. 10.1038/sj.bjc.6603065, 2361240, 16598187.
15. Liu D, Rudland PS, Sibson DR, Platt-Higgins A, Barraclough R. Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas. Cancer research 2005, 65(9):3796-3805. 10.1158/0008-5472.CAN-04-3823, 15867376.
16. Shen D, Chang HR, Chen Z, He J, Lonsberry V, Elshimali Y, Chia D, Seligson D, Goodglick L, Nelson SF, et al. Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analyses. Biochemical and biophysical research communications 2005, 326(1):218-227. 10.1016/j.bbrc.2004.10.214, 15567174.
17. Zhang JS, Gong A, Cheville JC, Smith DI, Young CY. AGR2, an androgen-inducible secretory protein overexpressed in prostate cancer. Genes, chromosomes & cancer 2005, 43(3):249-259. 10.1002/gcc.20188, 15834940.
18. Zhang Y, Ali TZ, Zhou H, D'Souza DR, Lu Y, Jaffe J, Liu Z, Passaniti A, Hamburger AW. ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer. Cancer research 2010, 70(1):240-248. 10.1158/0008-5472.CAN-09-2904, 20048076.
19. Zhang Y, Forootan SS, Liu D, Barraclough R, Foster CS, Rudland PS, Ke Y. Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients. Prostate cancer and prostatic diseases 2007, 10(3):293-300. 10.1038/sj.pcan.4500960, 17457305.
20. Liu AY, Zhang H, Sorensen CM, Diamond DL. Analysis of prostate cancer by proteomics using tissue specimens. The Journal of urology 2005, 173(1):73-78. 10.1097/01.ju.0000146543.33543.a3, 15592032.
21. Bu H, Bormann S, Schafer G, Horninger W, Massoner P, Neeb A, Lakshmanan VK, Maddalo D, Nestl A, Sultmann H, et al. The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection. Prostate 2010,
22. Vivekanandan P, Micchelli ST, Torbenson M. Anterior gradient-2 is overexpressed by fibrolamellar carcinomas. Hum Pathol 2009, 40(3):293-299. 10.1016/j.humpath.2008.08.003, 2746414, 18973922.
23. Riener MO, Pilarsky C, Gerhardt J, Grutzmann R, Fritzsche FR, Bahra M, Weichert W, Kristiansen G. Prognostic significance of AGR2 in pancreatic ductal adenocarcinoma. Histology and histopathology 2009, 24(9):1121-1128.
24. Lowe AW, Olsen M, Hao Y, Lee SP, Taek Lee K, Chen X, van de Rijn M, Brown PO. Gene expression patterns in pancreatic tumors, cells and tissues. PLoS One 2007, 2(3):e323. 10.1371/journal.pone.0000323, 1824711, 17389914.
25. Iacobuzio-Donahue CA, Maitra A, Olsen M, Lowe AW, van Heek NT, Rosty C, Walter K, Sato N, Parker A, Ashfaq R, et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol 2003, 162(4):1151-1162. 1851213, 12651607.
26. Lee S, Bang S, Song K, Lee I. Differential expression in normal-adenoma-carcinoma sequence suggests complex molecular carcinogenesis in colon. Oncol Rep 2006, 16(4):747-754.
27. Wang Z, Hao Y, Lowe AW. The adenocarcinoma-associated antigen, AGR2, promotes tumor growth, cell migration, and cellular transformation. Cancer research 2008, 68(2):492-497. 10.1158/0008-5472.CAN-07-2930, 18199544.
28. Wu ZS, Wu Q, Ding XD, Wang HQ, Shen YX, Fang SY. [Expression of a novel metastasis-inducing protein human anterior gradient-2 (AGR2) in breast cancer and its clinical and prognostic significance]. Zhonghua bing li xue za zhi Chinese journal of pathology 2008, 37(2):109-113.
29. Barraclough DL, Platt-Higgins A, de Silva Rudland S, Barraclough R, Winstanley J, West CR, Rudland PS. The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients. Am J Pathol 2009, 175(5):1848-1857. 10.2353/ajpath.2009.090246, 2774050, 19834055.
30. Fritzsche FR, Dahl E, Dankof A, Burkhardt M, Pahl S, Petersen I, Dietel M, Kristiansen G. Expression of AGR2 in non small cell lung cancer. Histology and histopathology 2007, 22(7):703-708.
31. Yu YP, Landsittel D, Jing L, Nelson J, Ren B, Liu L, McDonald C, Thomas R, Dhir R, Finkelstein S, et al. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol 2004, 22(14):2790-2799. 10.1200/JCO.2004.05.158, 15254046.
32. Lapointe J, Li C, Higgins JP, van de Rijn M, Bair E, Montgomery K, Ferrari M, Egevad L, Rayford W, Bergerheim U, et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(3):811-816. 10.1073/pnas.0304146101, 321763, 14711987.
33. Seligson D, Horvath S, Huerta-Yepez S, Hanna S, Garban H, Roberts A, Shi T, Liu X, Chia D, Goodglick L, et al. Expression of transcription factor Yin Yang 1 in prostate cancer. International journal of oncology 2005, 27(1):131-141.
34. Seligson DB, Hongo F, Huerta-Yepez S, Mizutani Y, Miki T, Yu H, Horvath S, Chia D, Goodglick L, Bonavida B. Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence. Clin Cancer Res 2007, 13(20):6056-6063. 10.1158/1078-0432.CCR-07-0960, 17947468.
35. Seligson DB, Horvath S, Shi T, Yu H, Tze S, Grunstein M, Kurdistani SK. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 2005, 435(7046):1262-1266. 10.1038/nature03672, 15988529.
36. Yoon NK, Seligson DB, Chia D, Elshimali Y, Sulur G, Li A, Horvath S, Maresh E, Mah V, Bose S, et al. Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcome. Cancer Biomark 2009, 5(4):215-224.
37. Mah V, Seligson DB, Li A, Marquez DC, Wistuba, Elshimali Y, Fishbein MC, Chia D, Pietras RJ, Goodglick L. Aromatase expression predicts survival in women with early-stage non small cell lung cancer. Cancer research 2007, 67(21):10484-10490. 10.1158/0008-5472.CAN-07-2607, 17974992.
38. Yoon NK, Maresh EL, Elshimali Y, Li A, Horvath S, Seligson DB, Chia D, Goodglick L. Elevated MED28 expression predicts poor outcome in women with breast cancer. BMC Cancer 2010, 10:335. 10.1186/1471-2407-10-335, 2907343, 20584319.
39. Tomlins SA, Mehra R, Rhodes DR, Cao X, Wang L, Dhanasekaran SM, Kalyana-Sundaram S, Wei JT, Rubin MA, Pienta KJ, et al. Integrative molecular concept modeling of prostate cancer progression. Nat Genet 2007, 39(1):41-51. 10.1038/ng1935, 17173048.
40. True L, Coleman I, Hawley S, Huang CY, Gifford D, Coleman R, Beer TM, Gelmann E, Datta M, Mostaghel E, et al. A molecular correlate to the Gleason grading system for prostate adenocarcinoma. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(29):10991-10996. 10.1073/pnas.0603678103, 1544162, 16829574.
41. Aberger F, Weidinger G, Grunz H, Richter K. Anterior specification of embryonic ectoderm: the role of the Xenopus cement gland-specific gene XAG-2. Mechanisms of development 1998, 72(1-2):115-130. 10.1016/S0925-4773(98)00021-5, 9533957.
42. Kumar A, Godwin JW, Gates PB, Garza-Garcia AA, Brockes JP. Molecular basis for the nerve dependence of limb regeneration in an adult vertebrate. Science (New York, NY) 2007, 318(5851):772-777.
43. Uhlen M, Bjorling E, Agaton C, Szigyarto CA, Amini B, Andersen E, Andersson AC, Angelidou P, Asplund A, Asplund C, et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics 2005, 4(12):1920-1932. 10.1074/mcp.M500279-MCP200, 16127175.
44. Park SW, Zhen G, Verhaeghe C, Nakagami Y, Nguyenvu LT, Barczak AJ, Killeen N, Erle DJ. The protein disulfide isomerase AGR2 is essential for production of intestinal mucus. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(17):6950-6955. 10.1073/pnas.0808722106, 2678445, 19359471.
45. Komiya T, Tanigawa Y, Hirohashi S. Cloning of the gene gob-4, which is expressed in intestinal goblet cells in mice. Biochimica et biophysica acta 1999, 1444(3):434-438.
46. Fletcher GC, Patel S, Tyson K, Adam PJ, Schenker M, Loader JA, Daviet L, Legrain P, Parekh R, Harris AL, et al. hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan. British journal of cancer 2003, 88(4):579-585. 10.1038/sj.bjc.6600740, 2377166, 12592373.
47. Smirnov DA, Zweitzig DR, Foulk BW, Miller MC, Doyle GV, Pienta KJ, Meropol NJ, Weiner LM, Cohen SJ, Moreno JG, et al. Global gene expression profiling of circulating tumor cells. Cancer research 2005, 65(12):4993-4997. 10.1158/0008-5472.CAN-04-4330, 15958538.
48. Kovalev LI, Shishkin SS, Khasigov PZ, Dzeranov NK, Kazachenko AV, Toropygin I, Mamykina SV. [Identification of AGR2 protein, a novel potential cancer marker, using proteomics technologies]. Prikl Biokhim Mikrobiol 2006, 42(4):480-484.